{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:11:19Z","timestamp":1783973479400,"version":"3.55.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Diabetes care is characterized by the widespread use of plastics. With plastic-associated endocrine-disrupting chemicals (EDCs) implicated in diabetes pathogenesis, this review examines how medical plastics relate to diabetes and related disorders and proposes interventions to improve the situation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Plastic-associated EDCs and micro-\/nanoplastics (MNPs) are linked to metabolic dysfunction. Medical care exposes patients to these agents; however, the precise contribution of diabetes care to these exposures and their associated adverse health effects remains poorly defined. Diabetes care is an increasingly important contributor to plastic pollution and climate change, yet inadequate systems exist to mitigate its environmental impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Plastic-associated EDCs and MNPs remain an underappreciated metabolic health threat. Mitigating the deleterious impacts of plastics on human and planetary health requires concerted actions from manufacturers, scientists, policymakers, professional organizations, healthcare providers, and patients. Doing so has the potential to improve metabolic health and promote health equity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11892-026-01635-4","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:17:02Z","timestamp":1783927022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasticizing Diabetes Care: The Metabolic Threat of Plastic-Associated Endocrine Disruptors and Micro-\/Nanoplastics in Clinical Medicine"],"prefix":"10.1007","volume":"26","author":[{"given":"Robert M.","family":"Sargis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirimon","family":"Reutrakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Trasande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"1635_CR1","unstructured":"International Diabetes Federation. Diabetes Atlas Brussels, Belgium: International Diabetes Federation. 2025 [11th:[Available from: http:\/\/www.idf.org\/diabetesatlas"},{"issue":"Supplement1","key":"1635_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.2337\/dc26-SINT","volume":"49","author":"American Diabetes Association","year":"2026","unstructured":"American Diabetes Association. Standards of Care in Diabetes\u20142026. Diabetes Care. 2026;49(Supplement1):S1\u2013371.","journal-title":"Diabetes Care"},{"issue":"4","key":"1635_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/er.2009-0002","volume":"30","author":"E Diamanti-Kandarakis","year":"2009","unstructured":"Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293\u2013342.","journal-title":"Endocr Rev"},{"issue":"6","key":"1635_CR4","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1210\/er.2015-1010","volume":"36","author":"AC Gore","year":"2015","unstructured":"Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. EDC-2: The Endocrine Society\u2019s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1\u2013150.","journal-title":"Endocr Rev"},{"key":"1635_CR5","unstructured":"Gore ALM, Patisaul MA, Sargis H. RM. Endocrine Disrupting Chemicals: Threats to Human Health Washington, DC: The Endocrine Society and IPEN; 2024 [updated February 2024. Available from: https:\/\/ipen.org\/sites\/default\/files\/documents\/edc_report-2024-final-compressed.pdf"},{"key":"1635_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","volume":"68","author":"JJ Heindel","year":"2017","unstructured":"Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3\u201333.","journal-title":"Reprod Toxicol"},{"key":"1635_CR7","doi-asserted-by":"publisher","first-page":"115015","DOI":"10.1016\/j.bcp.2022.115015","volume":"199","author":"JJ Heindel","year":"2022","unstructured":"Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, et al. Obesity II: Establishing causal links between chemical exposures and obesity. Biochem Pharmacol. 2022;199:115015.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1635_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s40572-017-0137-0","volume":"4","author":"MS Mimoto","year":"2017","unstructured":"Mimoto MS, Nadal A, Sargis RM. Polluted Pathways: Mechanisms of Metabolic Disruption by Endocrine Disrupting Chemicals. Curr Environ Health Rep. 2017;4(2):208\u201322.","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"1635_CR9","doi-asserted-by":"publisher","first-page":"wkag001","DOI":"10.1093\/enendo\/wkag001","volume":"2","author":"A Nadal","year":"2026","unstructured":"Nadal A, Fuentes E, Muncke J, Sargis RM. Microplastics, nanoplastics, and plastic chemicals: applying the key characteristics of metabolism disrupting agents shows reason for concern. Environ Endocrinol. 2026;2(1):wkag001.","journal-title":"Environ Endocrinol"},{"key":"1635_CR10","first-page":"18","volume":"85","author":"RM Sargis","year":"2012","unstructured":"Sargis RM, Howard SG, Newbold RR, Heindel JJ. The Diabetes Epidemic: Environmental Chemical Exposure in Etiology and Treatment. San Francisco Med. 2012;85:18\u20139.","journal-title":"San Francisco Med"},{"key":"1635_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4093\/dmj.2014.38.1.13","volume":"38","author":"RM Sargis","year":"2014","unstructured":"Sargis RM. The Hijacking of Cellular Signaling and the Diabetes Epidemic: Mechanisms of Environmental Disruption of Insulin Action and Glucose Homeostasis. Diabetes Metab J. 2014;38:1\u201312.","journal-title":"Diabetes Metab J"},{"key":"1635_CR12","doi-asserted-by":"crossref","unstructured":"Sargis RM. Metabolic disruption in context: clinical avenues for synergistic perturbations in energy homeostasis by endocrine disrupting chemicals. Endocr Disruptors. 2015;3(1):e1080788.","DOI":"10.1080\/23273747.2015.1080788"},{"issue":"4","key":"1635_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41574-024-01059-8","volume":"21","author":"MA La Merrill","year":"2025","unstructured":"La Merrill MA, Smith MT, McHale CM, Heindel JJ, Atlas E, Cave MC, et al. Consensus on the key characteristics of metabolism disruptors. Nat Rev Endocrinol. 2025;21(4):245\u201361.","journal-title":"Nat Rev Endocrinol"},{"key":"1635_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/bs.apha.2021.04.002","volume":"92","author":"MC Schulz","year":"2021","unstructured":"Schulz MC, Sargis RM. Inappropriately sweet: Environmental endocrine-disrupting chemicals and the diabetes pandemic. Adv Pharmacol. 2021;92:419\u201356.","journal-title":"Adv Pharmacol"},{"issue":"7","key":"1635_CR15","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2337\/db11-0153","volume":"60","author":"BA Neel","year":"2011","unstructured":"Neel BA, Sargis RM. The paradox of progress: environmental disruption of metabolism and the diabetes epidemic. Diabetes. 2011;60(7):1838\u201348.","journal-title":"Diabetes"},{"issue":"6","key":"1635_CR16","doi-asserted-by":"publisher","first-page":"E488","DOI":"10.1152\/ajpendo.00068.2023","volume":"324","author":"J Mart\u00ednez-Pinna","year":"2023","unstructured":"Mart\u00ednez-Pinna J, Sempere-Navarro R, Medina-Gali RM, Fuentes E, Quesada I, Sargis RM, et al. Endocrine disruptors in plastics alter \u03b2-cell physiology and increase the risk of diabetes mellitus. Am J Physiol Endocrinol Metab. 2023;324(6):E488\u2013505.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"1635_CR17","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00125-019-4940-z","volume":"62","author":"RM Sargis","year":"2019","unstructured":"Sargis RM, Simmons RA. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors. Diabetologia. 2019;62(10):1811\u201322.","journal-title":"Diabetologia"},{"issue":"2","key":"1635_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archinte.1979.03630390039016","volume":"139","author":"A Pont","year":"1979","unstructured":"Pont A, Rubino JM, Bishop D, Peal R. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med. 1979;139(2):185\u20137.","journal-title":"Arch Intern Med"},{"issue":"12","key":"1635_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2337\/diab.29.12.971","volume":"29","author":"JH Karam","year":"1980","unstructured":"Karam JH, Lewitt PA, Young CW, Nowlain RE, Frankel BJ, Fujiya H, et al. Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes. 1980;29(12):971\u20138.","journal-title":"Diabetes"},{"key":"1635_CR20","unstructured":"Flaws JD, Patisaul P, Gore HB, Raetzman A, Vandenberg L, Plastics LN, EDCs, Health. A Guide for Public Interest Organizations and Policy-Makers on Endocrine Disrupting Chemicals & Plastics Washington, DC: The Endocrine Society and IPEN; 2020 [Available from: https:\/\/www.endocrine.org\/-\/media\/endocrine\/files\/topics\/edc_guide_2020_v1_6chqennew-version.pdf"},{"issue":"4","key":"1635_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/1753-0407.12325","volume":"8","author":"Y Song","year":"2016","unstructured":"Song Y, Chou EL, Baecker A, You NC, Song Y, Sun Q, et al. Endocrine-disrupting chemicals, risk of type 2 diabetes, and diabetes-related metabolic traits: A systematic review and meta-analysis. J Diabetes. 2016;8(4):516\u201332.","journal-title":"J Diabetes"},{"key":"1635_CR22","doi-asserted-by":"publisher","first-page":"112109","DOI":"10.1016\/j.envres.2021.112109","volume":"204","author":"H Zhang","year":"2022","unstructured":"Zhang H, Ben Y, Han Y, Zhang Y, Li Y, Chen X. Phthalate exposure and risk of diabetes mellitus: Implications from a systematic review and meta-analysis. Environ Res. 2022;204:112109. Pt B).","journal-title":"Environ Res"},{"issue":"1","key":"1635_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12940-022-00858-8","volume":"21","author":"D Yan","year":"2022","unstructured":"Yan D, Jiao Y, Yan H, Liu T, Yan H, Yuan J. Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Environ Health. 2022;21(1):53.","journal-title":"Environ Health"},{"key":"1635_CR24","doi-asserted-by":"publisher","first-page":"103747","DOI":"10.1016\/j.eclinm.2025.103747","volume":"92","author":"S India Aldana","year":"2026","unstructured":"India Aldana S, Yu X, Yao M, Cohen N, Markopoulou E, Chowdhury M, et al. Associations of perfluoroalkyl and polyfluoroalkyl substances with markers of glycaemic control, insulin secretion and sensitivity, and diabetes risk: a systematic review and meta-analyses. EClinicalMedicine. 2026;92:103747.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"1635_CR25","doi-asserted-by":"publisher","first-page":"bvag011","DOI":"10.1210\/jendso\/bvag011","volume":"10","author":"L Wang","year":"2026","unstructured":"Wang L, Gerassimidou S, Geueke B, Groh KJ, Iacovidou E, Majid A, et al. Antimony: A Cryptic Metabolism Disruptor Ubiquitous in Food Contact Materials. J Endocr Soc. 2026;10(4):bvag011.","journal-title":"J Endocr Soc"},{"issue":"2","key":"1635_CR26","doi-asserted-by":"publisher","first-page":"bvad163","DOI":"10.1210\/jendso\/bvad163","volume":"8","author":"L Trasande","year":"2024","unstructured":"Trasande L, Krithivasan R, Park K, Obsekov V, Belliveau M. Chemicals Used in Plastic Materials: An Estimate of the Attributable Disease Burden and Costs in the United States. J Endocr Soc. 2024;8(2):bvad163.","journal-title":"J Endocr Soc"},{"issue":"4","key":"1635_CR27","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41591-024-03453-1","volume":"31","author":"AJ Nihart","year":"2025","unstructured":"Nihart AJ, Garcia MA, El Hayek E, Liu R, Olewine M, Kingston JD, et al. Bioaccumulation of microplastics in decedent human brains. Nat Med. 2025;31(4):1114\u20139.","journal-title":"Nat Med"},{"key":"1635_CR28","doi-asserted-by":"publisher","first-page":"106274","DOI":"10.1016\/j.envint.2020.106274","volume":"146","author":"A Ragusa","year":"2021","unstructured":"Ragusa A, Svelato A, Santacroce C, Catalano P, Notarstefano V, Carnevali O, et al. Plasticenta: First evidence of microplastics in human placenta. Environ Int. 2021;146:106274.","journal-title":"Environ Int"},{"issue":"2","key":"1635_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/toxsci\/kfae060","volume":"200","author":"CJ Hu","year":"2024","unstructured":"Hu CJ, Garcia MA, Nihart A, Liu R, Yin L, Adolphi N, et al. Microplastic presence in dog and human testis and its potential association with sperm count and weights of testis and epididymis. Toxicol Sci. 2024;200(2):235\u201340.","journal-title":"Toxicol Sci"},{"issue":"10","key":"1635_CR30","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJMoa2309822","volume":"390","author":"R Marfella","year":"2024","unstructured":"Marfella R, Prattichizzo F, Sardu C, Fulgenzi G, Graciotti L, Spadoni T, et al. Microplastics and Nanoplastics in Atheromas and Cardiovascular Events. N Engl J Med. 2024;390(10):900\u201310.","journal-title":"N Engl J Med"},{"issue":"6720","key":"1635_CR31","doi-asserted-by":"publisher","first-page":"eadl2746","DOI":"10.1126\/science.adl2746","volume":"386","author":"RC Thompson","year":"2024","unstructured":"Thompson RC, Courtene-Jones W, Boucher J, Pahl S, Raubenheimer K, Koelmans AA. Twenty years of microplastic pollution research-what have we learned? Science. 2024;386(6720):eadl2746.","journal-title":"Science"},{"key":"1635_CR32","doi-asserted-by":"publisher","first-page":"118585","DOI":"10.1016\/j.ecoenv.2025.118585","volume":"302","author":"Y Tang","year":"2025","unstructured":"Tang Y, Suo Y, Sun Z, Wu X, Xing Q, Bai Y. Microplastics induce insulin resistance by causing mitochondrial dysfunction associated with mROS in skeletal muscle in vitro. Ecotoxicol Environ Saf. 2025;302:118585.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1635_CR33","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.impact.2025.100549","volume":"37","author":"JE Kim","year":"2025","unstructured":"Kim JE, Sonar NS, Thakuri LS, Park JW, Kim KT, Rhyu DY. Mixtures of polystyrene micro and nanoplastics affects fat and glucose metabolism in 3T3-L1 adipocytes and zebrafish larvae. NanoImpact. 2025;37:100549.","journal-title":"NanoImpact"},{"key":"1635_CR34","doi-asserted-by":"publisher","first-page":"170700","DOI":"10.1016\/j.scitotenv.2024.170700","volume":"918","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wan B, Zheng J, Chen L, Xuan Y, Zhang R, et al. Polystyrene nanoplastics inhibit beige fat function and exacerbate metabolic disorder in high-fat diet-fed mice. Sci Total Environ. 2024;918:170700.","journal-title":"Sci Total Environ"},{"issue":"9","key":"1635_CR35","doi-asserted-by":"publisher","first-page":"4964","DOI":"10.3390\/ijms25094964","volume":"25","author":"Y Roh","year":"2024","unstructured":"Roh Y, Kim J, Song H, Seol A, Kim T, Park E, et al. Impact of the Oral Administration of Polystyrene Microplastics on Hepatic Lipid, Glucose, and Amino Acid Metabolism in C57BL\/6Korl and C57BL\/6-Lep(em1hwl)\/Korl Mice. Int J Mol Sci. 2024;25(9):4964.","journal-title":"Int J Mol Sci"},{"issue":"Pt 1","key":"1635_CR36","doi-asserted-by":"publisher","first-page":"155937","DOI":"10.1016\/j.scitotenv.2022.155937","volume":"838","author":"D Huang","year":"2022","unstructured":"Huang D, Zhang Y, Long J, Yang X, Bao L, Yang Z, et al. Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation. Sci Total Environ. 2022;838(Pt 1):155937.","journal-title":"Sci Total Environ"},{"issue":"15","key":"1635_CR37","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.3390\/ijms241512421","volume":"24","author":"AG Lee","year":"2023","unstructured":"Lee AG, Kang S, Yoon HJ, Im S, Oh SJ, Pak YK. Polystyrene Microplastics Exacerbate Systemic Inflammation in High-Fat Diet-Induced Obesity. Int J Mol Sci. 2023;24(15):12421.","journal-title":"Int J Mol Sci"},{"issue":"Pt 3","key":"1635_CR38","doi-asserted-by":"publisher","first-page":"132607","DOI":"10.1016\/j.chemosphere.2021.132607","volume":"288","author":"X Fan","year":"2022","unstructured":"Fan X, Wei X, Hu H, Zhang B, Yang D, Du H, et al. Effects of oral administration of polystyrene nanoplastics on plasma glucose metabolism in mice. Chemosphere. 2022;288(Pt 3):132607.","journal-title":"Chemosphere"},{"issue":"7","key":"1635_CR39","first-page":"3108","volume":"58","author":"Z Yang","year":"2024","unstructured":"Yang Z, Dong H, Gao Y, Liu S, Chen L, Ni G, et al. Airborne Nanoplastics Exposure Inducing Irreversible Glucose Increase and Complete Hepatic Insulin Resistance. Environ Sci Technol. 2024;58(7):3108\u201317.","journal-title":"Environ Sci Technol"},{"key":"1635_CR40","doi-asserted-by":"publisher","first-page":"113239","DOI":"10.1016\/j.ecoenv.2022.113239","volume":"232","author":"J Zhao","year":"2022","unstructured":"Zhao J, Gomes D, Jin L, Mathis SP, Li X, Rouchka EC, et al. Polystyrene bead ingestion promotes adiposity and cardiometabolic disease in mice. Ecotoxicol Environ Saf. 2022;232:113239.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1635_CR41","doi-asserted-by":"publisher","first-page":"107273","DOI":"10.1016\/j.envint.2022.107273","volume":"164","author":"C Shi","year":"2022","unstructured":"Shi C, Han X, Guo W, Wu Q, Yang X, Wang Y, et al. Disturbed Gut-Liver axis indicating oral exposure to polystyrene microplastic potentially increases the risk of insulin resistance. Environ Int. 2022;164:107273.","journal-title":"Environ Int"},{"key":"1635_CR42","doi-asserted-by":"publisher","first-page":"116492","DOI":"10.1016\/j.ecoenv.2024.116492","volume":"279","author":"R Zhang","year":"2024","unstructured":"Zhang R, Feng Y, Nie P, Wang W, Wu H, Wan X, et al. Polystyrene microplastics disturb maternal glucose homeostasis and induce adverse pregnancy outcomes. Ecotoxicol Environ Saf. 2024;279:116492.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"1","key":"1635_CR43","doi-asserted-by":"publisher","first-page":"39227","DOI":"10.1038\/s41598-025-21915-5","volume":"15","author":"K Mierzejewski","year":"2025","unstructured":"Mierzejewski K, Kurzynska A, Golubska M, Galecka I, Calka J, Bogacka I. Ingested PET microplastics alter the metabolomic profile of the porcine pancreas. Sci Rep. 2025;15(1):39227.","journal-title":"Sci Rep"},{"key":"1635_CR44","doi-asserted-by":"publisher","first-page":"125771","DOI":"10.1016\/j.envpol.2025.125771","volume":"368","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Cui M, Wang H, Yuan W, Liu Z, Gao H, et al. Co-exposure to F-53B and nanoplastics induced hepatic glucolipid metabolism disorders by the PI3K-AKT signaling pathway. Environ Pollut. 2025;368:125771.","journal-title":"Environ Pollut"},{"issue":"5","key":"1635_CR45","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1002\/tox.24125","volume":"39","author":"M Zhu","year":"2024","unstructured":"Zhu M, Li P, Xu T, Zhang G, Xu Z, Wang X, et al. Combined exposure to lead and microplastics increased risk of glucose metabolism in mice via the Nrf2\/NF-kappaB pathway. Environ Toxicol. 2024;39(5):2502\u201311.","journal-title":"Environ Toxicol"},{"key":"1635_CR46","doi-asserted-by":"publisher","first-page":"152514","DOI":"10.1016\/j.scitotenv.2021.152514","volume":"813","author":"X Chen","year":"2022","unstructured":"Chen X, Peng LB, Wang D, Zhu QL, Zheng JL. Combined effects of polystyrene microplastics and cadmium on oxidative stress, apoptosis, and GH\/IGF axis in zebrafish early life stages. Sci Total Environ. 2022;813:152514.","journal-title":"Sci Total Environ"},{"issue":"12","key":"1635_CR47","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1038\/s41591-025-04045-3","volume":"31","author":"A Monikh","year":"2025","unstructured":"Monikh A, Materi\u0107 F, Valsami-Jones D, Grossart E, Altmann H-P, Holzinger K. Challenges in studying microplastics in human brain. Nat Med. 2025;31(12):4034\u20135.","journal-title":"Nat Med"},{"issue":"12","key":"1635_CR48","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1038\/s41591-025-04046-2","volume":"31","author":"MJ Campen","year":"2025","unstructured":"Campen MJ, West AB, Garcia M, Gullapalli R, El Hayek E. Reply to: Challenges in studying microplastics in human brain. Nat Med. 2025;31(12):4036\u20137.","journal-title":"Nat Med"},{"key":"1635_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.aca.2018.07.028","volume":"1042","author":"F Gosetti","year":"2018","unstructured":"Gosetti F, Bolfi B, Robotti E, Manfredi M, Binotti M, Ferrero F, et al. Study of endocrine disrupting compound release from different medical devices through an on-line SPE UHPLC-MS\/MS method. Anal Chim Acta. 2018;1042:141\u201354.","journal-title":"Anal Chim Acta"},{"issue":"4","key":"1635_CR50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/anae.12083","volume":"68","author":"WJ Morton","year":"2013","unstructured":"Morton WJ, Muller CT, Goodwin N, Wilkes AR, Hall JE. Investigation of phthalate release from tracheal tubes. Anaesthesia. 2013;68(4):377\u201381.","journal-title":"Anaesthesia"},{"issue":"1","key":"1635_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12905-017-0398-7","volume":"17","author":"C Marie","year":"2017","unstructured":"Marie C, Hamlaoui S, Bernard L, Bourdeaux D, Sautou V, Lemery D, et al. Exposure of hospitalised pregnant women to plasticizers contained in medical devices. BMC Womens Health. 2017;17(1):45.","journal-title":"BMC Womens Health"},{"issue":"2","key":"1635_CR52","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-3148.2010.01056.x","volume":"21","author":"J Sampson","year":"2011","unstructured":"Sampson J, de Korte D. DEHP-plasticised PVC: relevance to blood services. Transfus Med. 2011;21(2):73\u201383.","journal-title":"Transfus Med"},{"key":"1635_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jpba.2015.10.034","volume":"118","author":"D Bourdeaux","year":"2016","unstructured":"Bourdeaux D, Yessaad M, Chennell P, Larbre V, Eljezi T, Bernard L, et al. Analysis of PVC plasticizers in medical devices and infused solutions by GC-MS. J Pharm Biomed Anal. 2016;118:206\u201313.","journal-title":"J Pharm Biomed Anal"},{"key":"1635_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.chemosphere.2015.11.067","volume":"145","author":"E Eckert","year":"2016","unstructured":"Eckert E, Munch F, Goen T, Purbojo A, Muller J, Cesnjevar R. Comparative study on the migration of di-2-ethylhexyl phthalate (DEHP) and tri-2-ethylhexyl trimellitate (TOTM) into blood from PVC tubing material of a heart-lung machine. Chemosphere. 2016;145:10\u20136.","journal-title":"Chemosphere"},{"issue":"9","key":"1635_CR55","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/biom9090403","volume":"9","author":"A Bacle","year":"2019","unstructured":"Bacle A, Dupuis A, Belmouaz M, Bauwens M, Cambien G, Venisse N, et al. Overexposure to Bisphenol A and Its Chlorinated Derivatives of Patients with End-Stage Renal Disease during Online Hemodiafiltration. Biomolecules. 2019;9(9):403.","journal-title":"Biomolecules"},{"issue":"2","key":"1635_CR56","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/all.12538","volume":"70","author":"K Breuer","year":"2015","unstructured":"Breuer K, Lipperheide C, Lipke U, Zapf T, Dickel H, Treudler R, et al. Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use. Allergy. 2015;70(2):220\u20136.","journal-title":"Allergy"},{"issue":"3","key":"1635_CR57","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1542\/peds.2012-1380","volume":"131","author":"SM Duty","year":"2013","unstructured":"Duty SM, Mendonca K, Hauser R, Calafat AM, Ye X, Meeker JD, et al. Potential sources of bisphenol A in the neonatal intensive care unit. Pediatrics. 2013;131(3):483\u20139.","journal-title":"Pediatrics"},{"issue":"5","key":"1635_CR58","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/AAP.0b013e3182a0e12f","volume":"38","author":"DA Provenzano","year":"2013","unstructured":"Provenzano DA, Liebert MA, Steen B, Lovetro D, Somers DL. Investigation of current infection-control practices for ultrasound coupling gel: a survey, microbiological analysis, and examination of practice patterns. Reg Anesth Pain Med. 2013;38(5):415\u201324.","journal-title":"Reg Anesth Pain Med"},{"issue":"4","key":"1635_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jhin.2011.07.010","volume":"79","author":"LE Shenep","year":"2011","unstructured":"Shenep LE, Shenep MA, Cheatham W, Hoffman JM, Hale A, Williams BF, et al. Efficacy of intravascular catheter lock solutions containing preservatives in the prevention of microbial colonization. J Hosp Infect. 2011;79(4):317\u201322.","journal-title":"J Hosp Infect"},{"issue":"7","key":"1635_CR60","first-page":"1057","volume":"15","author":"G Briassoulis","year":"2025","unstructured":"Briassoulis G, Ilia S, Briassouli E. Exposure to Per- and Polyfluoroalkyl Substances (PFASs) in Healthcare: Environmental and Clinical Insights. Life (Basel). 2025;15(7):1057.","journal-title":"Life (Basel)"},{"issue":"11","key":"1635_CR61","doi-asserted-by":"publisher","first-page":"117004","DOI":"10.1289\/EHP5564","volume":"127","author":"LM Iribarne-Duran","year":"2019","unstructured":"Iribarne-Duran LM, Artacho-Cordon F, Pena-Caballero M, Molina-Molina JM, Jimenez-Diaz I, Vela-Soria F, et al. Presence of Bisphenol A and Parabens in a Neonatal Intensive Care Unit: An Exploratory Study of Potential Sources of Exposure. Environ Health Perspect. 2019;127(11):117004.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"1635_CR62","doi-asserted-by":"publisher","first-page":"e429","DOI":"10.1542\/peds.113.5.e429","volume":"113","author":"AM Calafat","year":"2004","unstructured":"Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics. 2004;113(5):e429\u201334.","journal-title":"Pediatrics"},{"issue":"12","key":"1635_CR63","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/jp.2014.157","volume":"34","author":"EB Mallow","year":"2014","unstructured":"Mallow EB, Fox MA. Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks. J Perinatol. 2014;34(12):892\u20137.","journal-title":"J Perinatol"},{"issue":"4","key":"1635_CR64","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1289\/ehp.0800265","volume":"117","author":"AM Calafat","year":"2009","unstructured":"Calafat AM, Weuve J, Ye X, Jia LT, Hu H, Ringer S, et al. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect. 2009;117(4):639\u201344.","journal-title":"Environ Health Perspect"},{"issue":"Pt 1","key":"1635_CR65","doi-asserted-by":"publisher","first-page":"136687","DOI":"10.1016\/j.chemosphere.2022.136687","volume":"309","author":"K Strommen","year":"2022","unstructured":"Strommen K, Lyche JL, Moltu SJ, Muller MHB, Blakstad EW, Braekke K, et al. Estimated daily intake of phthalates, parabens, and bisphenol A in hospitalised very low birth weight infants. Chemosphere. 2022;309(Pt 1):136687.","journal-title":"Chemosphere"},{"issue":"9","key":"1635_CR66","doi-asserted-by":"publisher","first-page":"E413","DOI":"10.1111\/jpc.12244","volume":"49","author":"CJ Fischer","year":"2013","unstructured":"Fischer CJ, Bickle Graz M, Muehlethaler V, Palmero D, Tolsa JF. Phthalates in the NICU: is it safe? J Paediatr Child Health. 2013;49(9):E413\u20139.","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"1635_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1542\/peds.2008-1765","volume":"124","author":"H von Rettberg","year":"2009","unstructured":"von Rettberg H, Hannman T, Subotic U, Brade J, Schaible T, Waag KL, et al. Use of di(2-ethylhexyl)phthalate-containing infusion systems increases the risk for cholestasis. Pediatrics. 2009;124(2):710\u20136.","journal-title":"Pediatrics"},{"key":"1635_CR68","doi-asserted-by":"publisher","first-page":"108605","DOI":"10.1016\/j.envint.2024.108605","volume":"186","author":"L Panneel","year":"2024","unstructured":"Panneel L, Cleys P, Poma G, Ait Bamai Y, Jorens PG, Covaci A, et al. Ongoing exposure to endocrine disrupting phthalates and alternative plasticizers in neonatal intensive care unit patients. Environ Int. 2024;186:108605.","journal-title":"Environ Int"},{"issue":"41","key":"1635_CR69","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.3748\/wjg.v19.i41.7042","volume":"19","author":"ZR Gallinger","year":"2013","unstructured":"Gallinger ZR, Nguyen GC. Presence of phthalates in gastrointestinal medications: is there a hidden danger? World J Gastroenterol. 2013;19(41):7042\u20137.","journal-title":"World J Gastroenterol"},{"key":"1635_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2013.01.001","volume":"37","author":"S Hernandez-Diaz","year":"2013","unstructured":"Hernandez-Diaz S, Su YC, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates among women of childbearing age. Reprod Toxicol. 2013;37:1\u20135.","journal-title":"Reprod Toxicol"},{"issue":"3","key":"1635_CR71","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1289\/ehp.1103998","volume":"120","author":"KE Kelley","year":"2012","unstructured":"Kelley KE, Hernandez-Diaz S, Chaplin EL, Hauser R, Mitchell AA. Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. Environ Health Perspect. 2012;120(3):379\u201384.","journal-title":"Environ Health Perspect"},{"issue":"3","key":"1635_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/bcpt.12781","volume":"121","author":"A Broe","year":"2017","unstructured":"Broe A, Ennis ZN, Pottegard A, Hallas J, Ahern T, Damkier P. Population Exposure to Phthalate-containing Drugs. Basic Clin Pharmacol Toxicol. 2017;121(3):153\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"1635_CR73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1289\/ehp.11766","volume":"117","author":"S Hernandez-Diaz","year":"2009","unstructured":"Hernandez-Diaz S, Mitchell AA, Kelley KE, Calafat AM, Hauser R. Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect. 2009;117(2):185\u20139.","journal-title":"Environ Health Perspect"},{"issue":"8","key":"1635_CR74","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1111\/bcp.13614","volume":"84","author":"ZN Ennis","year":"2018","unstructured":"Ennis ZN, Broe A, Pottegard A, Ahern TP, Hallas J, Damkier P. Cumulative exposure to phthalates from phthalate-containing drug products: a Danish population-wide study. Br J Clin Pharmacol. 2018;84(8):1798\u2013805.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1635_CR75","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijheh.2018.08.008","volume":"222","author":"FL Nassan","year":"2019","unstructured":"Nassan FL, Korevaar TIM, Coull BA, Skakkebaek NE, Krawetz SA, Estill M, et al. Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in men. Int J Hyg Environ Health. 2019;222(1):101\u201310.","journal-title":"Int J Hyg Environ Health"},{"issue":"6","key":"1635_CR76","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnci\/djac045","volume":"114","author":"TP Ahern","year":"2022","unstructured":"Ahern TP, Spector LG, Damkier P, Ozturk Esen B, Ulrichsen SP, Eriksen K, et al. Medication-Associated Phthalate Exposure and Childhood Cancer Incidence. J Natl Cancer Inst. 2022;114(6):885\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"1635_CR77","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.envres.2018.12.033","volume":"172","author":"ME Romano","year":"2019","unstructured":"Romano ME, O\u2019Connell K, Du M, Rehm CD, Kantor ED. Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the National Health and Nutrition Examination Survey. Environ Res. 2019;172:437\u201343.","journal-title":"Environ Res"},{"key":"1635_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.reprotox.2015.02.002","volume":"52","author":"LE Dodge","year":"2015","unstructured":"Dodge LE, Kelley KE, Williams PL, Williams MA, Hernandez-Diaz S, Missmer SA, et al. Medications as a source of paraben exposure. Reprod Toxicol. 2015;52:93\u2013100.","journal-title":"Reprod Toxicol"},{"key":"1635_CR79","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.envres.2018.03.035","volume":"164","author":"LE Dodge","year":"2018","unstructured":"Dodge LE, Choi JW, Kelley KE, Hernandez DIS, Hauser R. Medications as a potential source of exposure to parabens in the U.S. population. Environ Res. 2018;164:580\u20134.","journal-title":"Environ Res"},{"issue":"3","key":"1635_CR80","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/molecules31030419","volume":"31","author":"BG de la Torre","year":"2026","unstructured":"de la Torre BG, Albericio F. The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of Molecules. Molecules. 2026;31(3):419.","journal-title":"Molecules"},{"issue":"5","key":"1635_CR81","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1021\/envhealth.4c00210","volume":"3","author":"T Huang","year":"2025","unstructured":"Huang T, Liu Y, Wang L, Ruan X, Ge Q, Ma M, et al. MPs Entering Human Circulation through Infusions: A Significant Pathway and Health Concern. Environ Health (Wash). 2025;3(5):551\u20139.","journal-title":"Environ Health (Wash)"},{"key":"1635_CR82","doi-asserted-by":"publisher","first-page":"140136","DOI":"10.1016\/j.jhazmat.2025.140136","volume":"499","author":"L Wang","year":"2025","unstructured":"Wang L, Peng J, Ji W, Tahir MA, Wang J, Wang T, et al. Nanoplastics in infusion system remains underexplored: Evidence from detected nanoplastics in hospital-sourced infusion products. J Hazard Mater. 2025;499:140136.","journal-title":"J Hazard Mater"},{"key":"1635_CR83","doi-asserted-by":"publisher","first-page":"138599","DOI":"10.1016\/j.jhazmat.2025.138599","volume":"494","author":"P Li","year":"2025","unstructured":"Li P, Xu H, Li Q, Lai Y, Yu S, Liu R, et al. Micro(nano)plastics (<\u20094 mum): An important but ignored concern during intravenous infusion. J Hazard Mater. 2025;494:138599.","journal-title":"J Hazard Mater"},{"key":"1635_CR84","doi-asserted-by":"publisher","first-page":"109377","DOI":"10.1016\/j.envint.2025.109377","volume":"198","author":"B Li","year":"2025","unstructured":"Li B, Li M, Du D, Tang B, Yi W, He M, et al. Characteristics and influencing factors of microplastics entering human blood through intravenous injection. Environ Int. 2025;198:109377.","journal-title":"Environ Int"},{"key":"1635_CR85","doi-asserted-by":"publisher","first-page":"136193","DOI":"10.1016\/j.jhazmat.2024.136193","volume":"480","author":"L Mou","year":"2024","unstructured":"Mou L, Wu C, Li R, Zhu Y, Su G, Zhang Y. Rapid detection of microplastics\/nanoplastics directly exposed to blood during intravenous injections via mie scattering spectra. J Hazard Mater. 2024;480:136193.","journal-title":"J Hazard Mater"},{"issue":"15","key":"1635_CR86","doi-asserted-by":"publisher","first-page":"e35101","DOI":"10.1016\/j.heliyon.2024.e35101","volume":"10","author":"J Wang","year":"2024","unstructured":"Wang J, Xie LG, Wu XF, Zhao ZG, Yang HY, Sun HM. Identification and quantification of micro-nano-plastics in polypropylene-bottled injections. Heliyon. 2024;10(15):e35101.","journal-title":"Heliyon"},{"key":"1635_CR87","doi-asserted-by":"publisher","first-page":"172648","DOI":"10.1016\/j.scitotenv.2024.172648","volume":"929","author":"A Tarafdar","year":"2024","unstructured":"Tarafdar A, Xie J, Gowen A, O\u2019Higgins AC, Xu JL. Advanced optical photothermal infrared spectroscopy for comprehensive characterization of microplastics from intravenous fluid delivery systems. Sci Total Environ. 2024;929:172648.","journal-title":"Sci Total Environ"},{"key":"1635_CR88","doi-asserted-by":"publisher","first-page":"343982","DOI":"10.1016\/j.aca.2025.343982","volume":"1355","author":"C Chen","year":"2025","unstructured":"Chen C, Du S, Liu Z, Li W, Tao F, Qie X. Systematic characterisation of microplastics released from disposable medical devices using laser direct infrared spectroscopy. Anal Chim Acta. 2025;1355:343982.","journal-title":"Anal Chim Acta"},{"key":"1635_CR89","doi-asserted-by":"publisher","first-page":"133246","DOI":"10.1016\/j.jhazmat.2023.133246","volume":"465","author":"X Zheng","year":"2024","unstructured":"Zheng X, Feng Q, Guo L. Quantitative analysis of microplastics and nanoplastics released from disposable PVC infusion tubes. J Hazard Mater. 2024;465:133246.","journal-title":"J Hazard Mater"},{"issue":"3","key":"1635_CR90","doi-asserted-by":"publisher","first-page":"37703","DOI":"10.1289\/EHP13491","volume":"132","author":"M Vercauteren","year":"2024","unstructured":"Vercauteren M, Panneel L, Jorens PG, Covaci A, Cleys P, Mulder A, et al. An Ex Vivo Study Examining Migration of Microplastics from an Infused Neonatal Parenteral Nutrition Circuit. Environ Health Perspect. 2024;132(3):37703.","journal-title":"Environ Health Perspect"},{"key":"1635_CR91","doi-asserted-by":"publisher","first-page":"135769","DOI":"10.1016\/j.jhazmat.2024.135769","volume":"480","author":"T Cui","year":"2024","unstructured":"Cui T, Liu K, Zhu L, Wang X, Dong X, Jabeen K, et al. Is intravenous infusion an unrecognized route for internal microplastic human exposure? A general assessment. J Hazard Mater. 2024;480:135769.","journal-title":"J Hazard Mater"},{"key":"1635_CR92","doi-asserted-by":"publisher","first-page":"139614","DOI":"10.1016\/j.jhazmat.2025.139614","volume":"497","author":"X Zhang","year":"2025","unstructured":"Zhang X, Shen R, Xia P, Tan H, Deng Y. Unraveling micro\/nanoplastics and phthalates in infusion solutions: A novel integrated approach for quantification and cardiovascular cytotoxicity evaluation. J Hazard Mater. 2025;497:139614.","journal-title":"J Hazard Mater"},{"key":"1635_CR93","doi-asserted-by":"publisher","first-page":"176468","DOI":"10.1016\/j.scitotenv.2024.176468","volume":"954","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wang D, Liu Z, Xu C, Zhang Y, Liu P. Microplastic injection? Identification and quantification of plastic particles in medical injections. Sci Total Environ. 2024;954:176468.","journal-title":"Sci Total Environ"},{"issue":"2","key":"1635_CR94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109\u201321.","journal-title":"N Engl J Med"},{"issue":"2","key":"1635_CR95","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"E-KCG The","year":"2023","unstructured":"The E-KCG, Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023;388(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"8","key":"1635_CR96","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","volume":"7","author":"O Mosenzon","year":"2019","unstructured":"Mosenzon O, Wiviott SD, Cahn A, Rozenberg A, Yanuv I, Goodrich EL, et al. Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial. Lancet Diabetes Endocrinol. 2019;7(8):606\u201317.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1635_CR97","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","volume":"375","author":"C Wanner","year":"2016","unstructured":"Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016;375(4):323\u201334.","journal-title":"N Engl J Med"},{"issue":"10","key":"1635_CR98","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMoa2410819","volume":"392","author":"AM Jastreboff","year":"2025","unstructured":"Jastreboff AM, le Roux CW, Stefanski A, Aronne LJ, Halpern B, Wharton S, et al. Tirzepatide for Obesity Treatment and Diabetes Prevention. N Engl J Med. 2025;392(10):958\u201371.","journal-title":"N Engl J Med"},{"issue":"12","key":"1635_CR99","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. N Engl J Med. 2021;384(12):1113\u201324.","journal-title":"N Engl J Med"},{"issue":"11","key":"1635_CR100","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989\u20131002.","journal-title":"N Engl J Med"},{"issue":"13","key":"1635_CR101","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391(13):1193\u2013205.","journal-title":"N Engl J Med"},{"issue":"4","key":"1635_CR102","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2401943","volume":"391","author":"R Loomba","year":"2024","unstructured":"Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, et al. Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. N Engl J Med. 2024;391(4):299\u2013310.","journal-title":"N Engl J Med"},{"issue":"3","key":"1635_CR103","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2337\/dc14-1096","volume":"38","author":"I Tikkanen","year":"2015","unstructured":"Tikkanen I, Narko K, Zeller C, Green A, Salsali A, Broedl UC, et al. Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension. Diabetes Care. 2015;38(3):420\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"1635_CR104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-8587(21)00295-3","volume":"10","author":"P Rossing","year":"2022","unstructured":"Rossing P, Inzucchi SE, Vart P, Jongs N, Docherty KF, Jhund PS, et al. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials. Lancet Diabetes Endocrinol. 2022;10(1):24\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1635_CR105","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"19","key":"1635_CR106","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"5","key":"1635_CR107","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2025;392(5):427\u201337.","journal-title":"N Engl J Med"},{"issue":"22","key":"1635_CR108","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"21","key":"1635_CR109","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"10366","key":"1635_CR110","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0140-6736(22)02033-5","volume":"400","author":"S Urva","year":"2022","unstructured":"Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. Lancet. 2022;400(10366):1869\u201381.","journal-title":"Lancet"},{"issue":"10401","key":"1635_CR111","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(23)01053-X","volume":"402","author":"J Rosenstock","year":"2023","unstructured":"Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529\u201344.","journal-title":"Lancet"},{"issue":"7","key":"1635_CR112","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1056\/NEJMoa2502082","volume":"393","author":"MJ Davies","year":"2025","unstructured":"Davies MJ, Bajaj HS, Broholm C, Eliasen A, Garvey WT, le Roux CW, et al. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes. N Engl J Med. 2025;393(7):648\u201359.","journal-title":"N Engl J Med"},{"issue":"20","key":"1635_CR113","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","volume":"392","author":"DK McGuire","year":"2025","unstructured":"McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, et al. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes. N Engl J Med. 2025;392(20):2001\u201312.","journal-title":"N Engl J Med"},{"issue":"11","key":"1635_CR114","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","volume":"393","author":"S Wharton","year":"2025","unstructured":"Wharton S, Lingvay I, Bogdanski P, Duque do Vale R, Jacob S, Karlsson T, et al. Oral Semaglutide at a Dose of 25\u00a0mg in Adults with Overweight or Obesity. N Engl J Med. 2025;393(11):1077\u201387.","journal-title":"N Engl J Med"},{"issue":"11","key":"1635_CR115","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","volume":"393","author":"J Rosenstock","year":"2025","unstructured":"Rosenstock J, Hsia S, Nevarez Ruiz L, Eyde S, Cox D, Wu WS, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med. 2025;393(11):1065\u201376.","journal-title":"N Engl J Med"},{"issue":"4","key":"1635_CR116","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/1932296816633721","volume":"10","author":"P Lasalvia","year":"2016","unstructured":"Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Castaneda-Cardona C, Bayona JG, et al. Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis. J Diabetes Sci Technol. 2016;10(4):959\u201366.","journal-title":"J Diabetes Sci Technol"},{"key":"1635_CR117","unstructured":"Novo Nordisk. Introducing ReMed: Driving Change to Avoid Plastic Waste 2026 [Available from: https:\/\/www.novonordisk.com\/sustainable-business\/zero-environmental-impact\/recycling-used-devices.html"},{"key":"1635_CR118","unstructured":"Eli Lilly and Company. Lilly to launch multi-dose weight-loss drug device in US Indianapolis, IN: Eli Lilly and Company. 2026 [Available from: https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/lilly-launch-multi-dose-weight-loss-drug-device-us-2026-02-23\/"},{"key":"1635_CR119","unstructured":"Food US, Administration D. FDA Clears First Device to Enable Automated Insulin Dosing for Individuals with Type 2 Diabetes 2024 [Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-device-enable-automated-insulin-dosing-individuals-type-2-diabetes"},{"key":"1635_CR120","unstructured":"U.S. Food and Drug Administration. MiniMed 780G System for use with Guardian 4 Sensor and Guardian 4 Transmitter Washington, DC2025 [Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160017S124A.pdf"},{"key":"1635_CR121","unstructured":"U.S. Food and Drug Administration. Tandem Control-IQ+ Technology Washington, DC2025 [Available from: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf24\/K243823.pdf"},{"issue":"11","key":"1635_CR122","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3390\/toxics13110926","volume":"13","author":"D Felek","year":"2025","unstructured":"Felek D, Erkoc MF, Yaylaci M, Turksoy VA. Assessment of Microplastic Exposure in Diabetic Patients Using Insulin. Toxics. 2025;13(11):926.","journal-title":"Toxics"},{"issue":"10507","key":"1635_CR123","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S0140-6736(25)01447-3","volume":"406","author":"PJ Landrigan","year":"2025","unstructured":"Landrigan PJ, Dunlop S, Treskova M, Raps H, Symeonides C, Muncke J, et al. The Lancet Countdown on health and plastics. Lancet. 2025;406(10507):1044\u201362.","journal-title":"Lancet"},{"issue":"1","key":"1635_CR124","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5334\/aogh.4056","volume":"89","author":"PJ Landrigan","year":"2023","unstructured":"Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, et al. The Minderoo-Monaco Commission on Plastics and Human Health. Ann Glob Health. 2023;89(1):23.","journal-title":"Ann Glob Health"},{"issue":"7","key":"1635_CR125","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2337\/dc24-2522","volume":"48","author":"T Tian","year":"2025","unstructured":"Tian T, Ho CN, Ayers AT, Aaron RE, Klonoff DC, Ahn DT, et al. Quantifying Environmental Waste From Diabetes Devices in the U.S. Diabetes Care. 2025;48(7):1198\u2013203.","journal-title":"Diabetes Care"},{"issue":"7","key":"1635_CR126","first-page":"807","volume":"29","author":"JE Biskupiak","year":"2023","unstructured":"Biskupiak JE, Ramos M, Levy CJ, Forlenza G, Hopley C, Boyd J, et al. Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. J Manag Care Spec Pharm. 2023;29(7):807\u201317.","journal-title":"J Manag Care Spec Pharm"},{"key":"1635_CR127","doi-asserted-by":"publisher","first-page":"100433","DOI":"10.1016\/j.joclim.2025.100433","volume":"22","author":"JS Perez","year":"2025","unstructured":"Perez JS, Hudson H, Araneta J, Bedell B, Aikins AD, Dugas LR, et al. Colliding crises: The global diabetes pandemic meets climate change-A scoping review. J Clim Chang Health. 2025;22:100433.","journal-title":"J Clim Chang Health"},{"issue":"10","key":"1635_CR128","doi-asserted-by":"publisher","first-page":"e3822","DOI":"10.1210\/clinem\/dgaa358","volume":"105","author":"M Genco","year":"2020","unstructured":"Genco M, Anderson-Shaw L, Sargis RM. Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care. J Clin Endocrinol Metab. 2020;105(10):e3822\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1635_CR129","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","volume":"44","author":"F Hill-Briggs","year":"2020","unstructured":"Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care. 2020;44(1):258\u201379.","journal-title":"Diabetes Care"},{"issue":"1","key":"1635_CR130","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc16-2765","volume":"41","author":"D Ruiz","year":"2018","unstructured":"Ruiz D, Becerra M, Jagai JS, Ard K, Sargis RM. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations. Diabetes Care. 2018;41(1):193\u2013205.","journal-title":"Diabetes Care"},{"issue":"4","key":"1635_CR131","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ecl.2023.05.009","volume":"52","author":"MC Weiss","year":"2023","unstructured":"Weiss MC, Wang L, Sargis RM. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities. Endocrinol Metab Clin North Am. 2023;52(4):719\u201336.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1635_CR132","doi-asserted-by":"publisher","first-page":"100591","DOI":"10.1016\/j.coemr.2025.100591","volume":"41","author":"L Wang","year":"2025","unstructured":"Wang L, Flores J, Sargis RM. Disparities in Endocrine-Disrupting Chemical Exposures and Thyroid Disorders. Curr Opin Endocr Metabolic Res. 2025;41:100591.","journal-title":"Curr Opin Endocr Metabolic Res"},{"issue":"7","key":"1635_CR133","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1111\/jocn.17110","volume":"33","author":"G Gangqiang","year":"2024","unstructured":"Gangqiang G, Hua C, Hongyu S. Risk predictors of glycaemic control in children and adolescents with type 1 diabetes: A systematic review and meta-analysis. J Clin Nurs. 2024;33(7):2412\u201326.","journal-title":"J Clin Nurs"},{"issue":"11","key":"1635_CR134","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1089\/dia.2022.0206","volume":"24","author":"GP Forlenza","year":"2022","unstructured":"Forlenza GP, Carlson AL, Galindo RJ, Kruger DF, Levy CJ, McGill JB, et al. Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations. Diabetes Technol Ther. 2022;24(11):814\u201323.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1635_CR135","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/26350106221145323","volume":"49","author":"CJ Howe","year":"2023","unstructured":"Howe CJ, Morone J, Hawkes CP, Lipman TH. Racial Disparities in Technology Use in Children With Type 1 Diabetes: A Qualitative Content Analysis of Parents\u2019 Perspectives. Sci Diabetes Self Manag Care. 2023;49(1):55\u201364.","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"1","key":"1635_CR136","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/19322968241275963","volume":"19","author":"ML Tanenbaum","year":"2025","unstructured":"Tanenbaum ML, Commissariat PV, Wilmot EG, Lange K. Navigating the Unique Challenges of Automated Insulin Delivery Systems to Facilitate Effective Uptake, Onboarding, and Continued Use. J Diabetes Sci Technol. 2025;19(1):47\u201353.","journal-title":"J Diabetes Sci Technol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-026-01635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-026-01635-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-026-01635-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:02:06Z","timestamp":1783972926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-026-01635-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1635"],"URL":"https:\/\/doi.org\/10.1007\/s11892-026-01635-4","relation":{},"ISSN":["1539-0829"],"issn-type":[{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RMS declares that he has received honoraria from CVS\/Health unrelated to the work presented herein. None of the other authors has any potential conflicts of interest. The views expressed in this article are those of the authors and do not necessarily reflect the positions or policies of the Department of Veterans Affairs or the United States government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Studies and Informed Consent"}}],"article-number":"21"}}